title: Detection of hypermethylated fibrillin-1 in the stool samples of colorectal cancer patients.
abstract: Prior studies have demonstrated that analysis of gene promoter methylation in stool samples may be a potential biomarker for noninvasive colorectal cancer detection. Aberrant methylation in gene promoter is common in various cancers, and epigenetic alterations can result in down-regulation or silence of gene expression. Recently, hypermethylation of fibrillin-1 (FBN1) was reported to be associated with colorectal cancer (CRC). In this study, we examined the methylation status of FBN1 in stool samples to test CRC. For the purpose of colorectal cancer detection, we investigated FBN1 hypermethylation in the tissue and stool samples of colorectal cancer patients using methylation-specific polymerase chain reaction. The result is that out of 75 patients with colorectal cancer, 59 (78.7%) exhibited hypermethylated FBN1 in their tumor tissue DNA. We next detected the methylation status of FBN1 in the stool DNA of these patients. The hypermethylated FBN1 occurred in 72% (54/75) of these patients in their stool samples and occurred in 6.7% (2/30) of healthy people (P < 0.001). The results indicated 72.0% sensitivity and 93.3% specificity of the test for detecting CRC by using stool samples. So, the study reveals that hypermethylation status in the promoter of FBN1 is a high specific and sensitive biomarker for colorectal cancer, and detecting hypermethylated FBNI in stool samples is a noninvasive and useful method for screening colorectal cancer.
authors: Department of Surgical Oncology, The First Affiliated Hospital, Xi'an Jiaotong University College of Medicine, 277W, Yanta Road, Xi'an, 710061, Shaanxi, China.
authors: Qi
authors: Q
authors: Guo
authors: Yongchun
authors: Y
authors: Song
authors: Hao
authors: H
authors: Zhang
authors: Xuandi
authors: X
authors: Wu
authors: Peng
authors: P
authors: Xia
authors: Chengxue
authors: C
authors: Dang
mesh_terms: D000368:Aged; D014408:Biomarkers, Tumor / Q000737:chemistry / Q000235:genetics; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000235:genetics*; D019175:DNA Methylation / Q000235:genetics; D055088:Early Detection of Cancer / Q000379:methods*; D005243:Feces / Q000737:chemistry*; D005260:Female; D000071838:Fibrillin-1; D000071837:Fibrillins; D006801:Humans; D008297:Male; D008840:Microfilament Proteins / Q000737:chemistry* / Q000235:genetics*; D008875:Middle Aged; D011401:Promoter Regions, Genetic / Q000235:genetics; D012680:Sensitivity and Specificity; D054392:Adipokines
chemical_list: D014408:Biomarkers, Tumor; D000071838:Fibrillin-1; D000071837:Fibrillins; D008840:Microfilament Proteins; C000605722:FBN1 protein, human; D054392:Adipokines
references: Int J Oncol. 2009 Aug;35(2):321-7
references: 19578746
references: Int J Med Sci. 2013;10(3):230-4
references: 23372428
references: Clin Cancer Res. 2009 Jun 15;15(12):3990-7
references: 19509152
references: Mol Vis. 2012;18:81-6
references: 22262941
references: Cancer Lett. 2002 Dec 15;188(1-2):115-9
references: 12406556
references: Cancer Res. 2000 Feb 15;60(4):892-5
references: 10706101
references: Mol Cancer. 2011 Jul 21;10:85
references: 21777459
references: Lancet. 1996 Nov 30;348(9040):1472-7
references: 8942775
references: Gastroenterology. 2005 Jan;128(1):192-206
references: 15633136
references: Cancer Res. 2007 May 1;67(9):4138-48
references: 17483324
references: Cell Oncol (Dordr). 2012 Aug;35(4):309-15
references: 22821210
references: Clin Chem. 2003 Jul;49(7):1185-7
references: 12816918
references: CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29
references: 22237781
references: Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9236-41
references: 10430926
references: Gastroenterology. 2000 Nov;119(5):1219-27
references: 11054379
references: Clin Cancer Res. 2002 Jan;8(1):188-91
references: 11801557
references: JAMA. 1993 Mar 10;269(10):1262-7
references: 8437303
references: N Engl J Med. 2004 Dec 23;351(26):2704-14
references: 15616205
references: J Natl Compr Canc Netw. 2010 Jan;8(1):8-61
references: 20064289
references: Cancer Metastasis Rev. 2010 Mar;29(1):181-206
references: 20135198
references: Mol Cancer. 2008 Oct 23;7:81
references: 18947422
references: Int J Cancer. 2003 Jul 1;105(4):491-3
references: 12712439
references: Clin Colorectal Cancer. 2010 Jul;9(3):168-76
references: 20643622